General Information of the Compound
| Compound ID |
CP0155823
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[[(3S,4R)-4-(4-chlorophenyl)piperidin-3-yl]methoxy]-2,5-difluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H21ClF3N3O3S
|
||||||||||||||||||
| Molecular Weight |
511.953
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(NS(=O)(=O)c2cc(F)c(OC[C@@H]3CNCC[C@H]3c3ccc(Cl)cc3)cc2F)nc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H21ClF3N3O3S/c24-16-3-1-14(2-4-16)18-7-8-28-11-15(18)13-33-21-9-20(27)22(10-19(21)26)34(31,32)30-23-6-5-17(25)12-29-23/h1-6,9-10,12,15,18,28H,7-8,11,13H2,(H,29,30)/t15-,18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VIKCAELOKQWDBV-YJBOKZPZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha